Phibro Animal Health Corporation - (PAHC) News

Phibro Animal Health Corporation - (PAHC)

Today's Latest Price: $21.25 USD

0.07 (-0.33%)

Updated Jan 22 4:00pm

Add PAHC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

StocksNews Articles for PAHC

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest PAHC News From Around the Web

Below are the latest news stories about Phibro Animal Health Corp that investors may wish to consider to help them evaluate PAHC as an investment opportunity.

PAHC vs. SRDX: Which Stock Should Value Investors Buy Now?

PAHC vs. SRDX: Which Stock Is the Better Value Option?

Yahoo | January 20, 2021

Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

Yahoo | January 12, 2021

TULISSIN® 100 Brand of Tulathromycin Now Approved by Health Canada

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health will represent and market Virbac’s newly approved TULISSIN® 100 brand of tulathromycin.

Business Wire | December 29, 2020

Why Phibro Animal Health Corporation (NASDAQ:PAHC) Looks Like A Quality Company

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | December 25, 2020

Veterinary Care Market for Asia and Latin America Worth USD 23 and USD 9 billion, by 2025 - Leading Companies are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France

According to the new market research report "Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region - Forecasts to 2025 ", published

OpenPR | December 16, 2020

Is PAHC A Good Stock To Buy Now?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial […]

Yahoo | December 16, 2020

Global Animal Treatment Market 2020:The Next Booming Segment In The World||Leading Players-Boehringer Ingelheim International GmbH.; Elanco; Ceva; Phibro Animal Health Corporation; Abaxis

Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Animal Treatment Market, By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, Poultry), Treatment (No Medicalization, Basic Medicalization, Veterinary Care), Country (U.S., Canada, Mexico, Germany, Italy,

OpenPR | December 14, 2020

Why Is Phibro (PAHC) Up 1.4% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 4, 2020

Phibro (PAHC) Hurt by Adverse Pricing in Mineral Nutrition Arm

Lower sales of Phibro's (PAHC) Performance Products arm's copper-based products raise concerns.

Yahoo | November 24, 2020

Anti-Coccidial Drugs Market Segments, Industry News, Regional Analysis and Forecast to 2027|Global Market Player - are Impextraco NV, Vetoquinol SA, Phibro Animal Health Corporation

Market Insights Global anti-coccidial drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets

OpenPR | November 18, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6795 seconds.